Skip to main content

toppbild-press-1551x278.jpg

Press

Interview with CEO Anna Ljung

Link to video »

All pressreleases
Regulatory

2024-09-13 | Press release

Moberg Pharma lowers expectations on primary endpoint in ongoing phase 3 trial following data in a subset of patients

2024-08-13 | Press release

Moberg Pharma´s interim report January - June 2024

2024-07-31 | Press release

New number of shares and votes in Moberg Pharma AB (publ)

2024-09-13 | Press release

Moberg Pharma lowers expectations on primary endpoint in ongoing phase 3 trial following data in a subset of patients

2024-08-13 | Press release

Moberg Pharma´s interim report January - June 2024

2024-07-31 | Press release

New number of shares and votes in Moberg Pharma AB (publ)

Read more press releases »

Latest report

2024-08-13 Moberg Pharma´s interim report January - June 2024

Contact for press och media:

Anna Ljung, CEO
Phone: +46 8 522 307 08
Email: anna.ljung@mobergpharma.se

Subscribe

Calendar/presentations

Next calendar event: 2024-10-08 At the heart of Pharma, CPHI Global Conference in Milan